Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

ACHILLION PHARMACEUTICALS INC (ACHN) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $0.20 Metrics
OS: 140.0 M -34 % ROE
Market cap: $28 M -426 % ROIC
Net cash: $229 M $1.63 per share
EV:

 
TTM Valuation
EBITDA ($79.1) M
EBIT ($80.2) M
EPS ($0.54)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11
Revenues0.00.015.066.10.00.02.60.2
            Revenue growth -100.0%-77.3%  -100.0%955.5%-89.9%
Cost of goods sold0.00.00.00.00.00.00.00.0
Gross profit0.00.015.066.10.00.02.60.2
            Gross margin  100.0%100.0%  100.0%100.0%
Research and development50.163.656.856.653.546.739.035.4
General and administrative23.926.023.024.715.912.710.99.2
EBIT-74.0-89.6-64.9-15.1-69.4-59.5-47.3-44.3
            EBIT margin  -432.4%-22.8%  -1814.1%-17954.3%
Pre-tax income-70.3-85.2-61.7-5.0-69.0-58.9-47.1-44.2
Income taxes0.00.00.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income-70.3-85.2-61.7-5.0-69.0-58.9-47.1-44.2
            Net margin  -411.4%-7.6%  -1807.7%-17897.2%
 
Diluted EPS($0.51)($0.62)($0.45)($0.04)($0.70)($0.63)($0.64)($0.69)
Shares outstanding (diluted)138.4137.2136.7125.698.494.074.064.2
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy